MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Salix Pharmaceuticals Company Profile (NASDAQ:SLXP)

Consensus Ratings for Salix Pharmaceuticals (NASDAQ:SLXP) (?)
Ratings Breakdown: 12 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Hold (Score: 2.20)
Consensus Price Target: $139.50 (19.28% downside)

Current Analysts' Coverage Summary for Salix Pharmaceuticals (NASDAQ:SLXP)
Show:
DateFirmActionRatingPrice TargetActions
3/18/2015Jefferies GroupDowngradeBuy -> Hold$149.00 -> $173.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2015MizuhoBoost Price TargetNeutral$158.00 -> $173.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/24/2015Cantor FitzgeraldDowngradeBuy -> Hold$151.00 -> $158.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/23/2015Leerink SwannDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/23/2015Piper JaffrayDowngradeOverweight -> Neutral$160.00 -> $158.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/12/2015Sterne Agee CRTDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/18/2014Deutsche BankReiterated RatingHold$107.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/18/2014Goldman SachsReiterated RatingHOLD$111.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/18/2014Credit SuisseBoost Price TargetNeutral$111.00 -> $121.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/17/2014Canaccord GenuityBoost Price TargetBuy$117.00 -> $147.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/7/2014Roth CapitalDowngradeBuy -> Neutral$155.00 -> $95.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/7/2014Stifel NicolausDowngradeBuy -> Hold$185.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/7/2014William BlairDowngradeOutperform -> Market Perform$184.00 -> $89.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/20/2014JMP SecuritiesReiterated RatingMarket Outperform$173.00 -> $190.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2014Keefe, Bruyette & WoodsReiterated RatingOutperform$160.00 -> $147.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/10/2014Brean CapitalBoost Price TargetBuy$125.00 -> $150.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/10/2014Wells Fargo & Co.Initiated CoverageMarket Perform$126.00 -> $130.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/18/2014National Alliance SecuritiesInitiated CoverageBuy$134.62View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2014Bank of AmericaDowngradeNeutral -> Underperform$86.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/19/2013Janney Montgomery ScottReiterated RatingBuy$95.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/11/2013SusquehannaBoost Price Target$75.00 -> $81.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/3/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha